U.S. Physicians Overwhelmingly Support Current FDA Data Standards, Switching Studies for Interchangeable Biosimilars; Oppose Pharmacy Substitution of Non-Interchangeable Biosimilars
ARLINGTON, VA / ACCESSWIRE / September 4, 2024 / U.S. physicians overwhelmingly support maintaining the Food and Drug Administration's (FDA's)...